GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3576 - 3600 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgG Patient 2 15 mild
G91537AT
1013
IgG Patient 3 11 mild
G17689EW
1019
IgM Patient 1 6 moderate
G15407YE
1020
IgA Patient 3 4 mild
G80587NA
1020
IgA Patient 2 3 mild
G54064FW
1022
IgM Patient 3 11 mild
G49916XD
1022
IgM Patient 3 4 mild
G49916XD
1024
IgM Patient 4 12 mild
G98068PA
1027
IgA Patient 2 15 mild
G00066MO
1035
IgM Patient 3 -180 mild
G42666HT
1037
IgM Patient 3 11 mild
G82096UQ
1037
IgA Patient 4 12 mild
G71142DF
1037
IgA Patient 4 12 mild
G35446HX
1038
IgG Patient 2 15 mild
G38488WF
1049
IgA Patient 3 -180 mild
G43648DB
1049
IgM Patient 2 24 mild
G17689EW
1054
IgM Patient 4 12 mild
G58969RU
1063
IgG Patient 3 4 mild
G71469XA
1066
IgM Patient 3 11 mild
G90562PB
1069
IgA Patient 2 24 mild
G47362BJ
1074
IgM Patient 3 -180 mild
G64669AQ
1075
IgA Patient 2 3 mild
G25559RS
1082
IgA Patient 3 11 mild
G00068MO
1083
IgA Patient 2 15 mild
G81315DD
1098
IgM Patient 4 12 mild
G53168IY
1104

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024